Clinical Trial: Oxytocin Effects on Bone Metabolism in Children With Autism Spectrum Disorder
Study Status: Completed
Recruit Status: RECRUITING
Condition: Autism Spectrum Disorder
Study Type: INTERVENTIONAL
Official Title: A Randomized, Double-blind, Placebo-controlled Study of Intranasal Oxytocin for Bone Health in Children With Autism Spectrum Disorder
Brief Summary:
This is a randomized, double blind, placebo-controlled study of the effects of intranasal oxytocin on bone health in children with autism spectrum disorder, ages 6-18 years old.Subjects will be randomized to receive intranasal oxytocin or placebo (30 IU, 2 times daily) for 12 months in the double-blind phase, followed by a 6-month open label phase during which all study subjects will receive intranasal oxytocin (30 IU, 2 times daily).Study visits include screening to determine eligibility, followed by study visits…
Read more